Related Experiment Video

Updated: Aug 7, 2025

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients
07:42

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on: February 7, 2021

5.0K

CD66b as a prognostic and predictive biomarker in patients with non-small cell lung cancer treated with checkpoint

Swati Jain1, Kevin Ma1, Luc G T Morris1

  • 1Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Translational Cancer Research
|March 14, 2023
PubMed
Abstract

No abstract available in PubMed .

Keywords:
CD66bNon-small cell lung cancer (NSCLC)biomarkerdigital spatial profilingtumor associated neutrophils

More Related Videos

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence10:29

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence

Published on: August 14, 2019

10.6K
Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood06:07

Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood

Published on: February 5, 2020

5.8K

Related Concept Videos